Pauls Matthew
Pelthos Therapeutics Inc. · Director
Pauls Matthew is listed in filings as Director at Pelthos Therapeutics Inc.. This profile follows SEC Form 4 activity through Apr 6, 2026, including sale activity. Recent filings connect the profile to Pelthos Therapeutics Inc. (PTHS) and Savara Inc. (SVRA). The current snapshot covers public activity from Dec 16, 2024 to Apr 6, 2026. Reported amounts are shown as $8.5K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $8.5k415 shares | SellApr 2, 2026 | $20.52 | $26.82 | |
| $7.9k371 shares | SellApr 2, 2026 | $21.36 | $26.82 |